Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 1714

Sort by

Sort Order Select

Journal Articles

The role of CD38 in monocytes during fibrotic progression of myeloproliferative neoplasms

Yiru Yan, Jinqin Liu, Songyang Zhao, Fuhui Li, Lin Yang, Zefeng Xu, Tiejun Qin, Xiaofan Zhu, Wenbin An, Zhongxun Shi, Wenyi Shen, Peihong Zhang, Gang Huang, Raajit K. Rampal, Zhijian Xiao, Bing Li

Blood blood.2025028703.

https://doi.org/10.1182/blood.2025028703

Published: 2025

Includes: Supplemental data

Journal Articles

The glycosaminoglycan oncofetal chondroitin sulfate represents a novel target for antibody drug-conjugate therapy for AML

Blood blood.2024028147.

https://doi.org/10.1182/blood.2024028147

Published: 2025

Includes: Supplemental data

Journal Articles

Pharmacological Inhibition of miR-126 Enhances Venetoclax Activity in Acute Myeloid Leukemia

Blood blood.2025029875.

https://doi.org/10.1182/blood.2025029875

Published: 2025

Includes: Supplemental data

Journal Articles

2025 Update on MRD in Acute Myeloid Leukemia: A Consensus Document from the ELN-DAVID MRD Working Party

Blood blood.2025031480.

https://doi.org/10.1182/blood.2025031480

Published: 2025

Includes: Supplemental data

Journal Articles

Microenvironmental cell interactions are essential for sustaining functionality of myelofibrosis malignant stem cells

Min Lu, Md. Babu Mia, Lijuan Xia, Gohar Mosoyan, Momina Hayat, Christoph Schaniel, Ronald Hoffman

Blood blood.2025031454.

https://doi.org/10.1182/blood.2025031454

Published: 2025

Includes: Supplemental data

Journal Articles

CUX1 restrains latent hematopoietic stem cell plasticity by suppressing stem cell–intrinsic inflammatory pathways

Tanner C. Martinez, Matthew R. M. Jotte, Saira Khan, Angela Stoddart, Hunter Blaylock, Ankit Malik, Megan E. McNerney

Blood (2025) 146 (24): 2914–2930.

https://doi.org/10.1182/blood.2024026815

Published: 2025

Includes: Supplemental data

Journal Articles

Fusion gene depletion eliminates stemness and induces bidirectional differentiation of acute myeloid leukemia

Polina K. Derevyanko, Laura E. Swart, L. Daniel Mata Casimiro, Anita van Oort, Manisha du Plessis, Luca van den Brink, Minoo Ashtiani, C. Michel Zwaan, Anja Krippner-Heidenreich, Constanze Bonifer, Raymond Schiffelers, Josef Vormoor, Sophie G. Kellaway, Olaf Heidenreich

Blood (2025) 146 (24): 2963–2978.

https://doi.org/10.1182/blood.2025028988

Published: 2025

Includes: Supplemental data

Journal Articles

Azacitidine to treat measurable residual disease in patients with MDS/AML: final long-term results of the RELAZA2 trial

Blood blood.2025030816.

https://doi.org/10.1182/blood.2025030816

Published: 2025

Includes: Supplemental data

Journal Articles

Impact of ASXL1 at diagnosis in patients with CML receiving frontline potent TKIs: high risk of kinase domain mutations

Blood (2025) 146 (23): 2821–2832.

https://doi.org/10.1182/blood.2025030259

Published: 2025

Includes: Supplemental data

Journal Articles

How I Treat Advanced Phases of CML

Michael J. Mauro

Blood blood.2024026510.

https://doi.org/10.1182/blood.2024026510

Published: 2025

Journal Articles

Improved diagnostic screening and classification of clonal mast cell diseases by ultrasensitive KIT p.D816V detection

Paula Navarro-Navarro, María González-Tablas, Alba Pérez-Pons, Laura Sánchez-Muñoz, Ana Henriques, Iván Álvarez-Twose, Paula Nafria, David Araco-Sánchez, Cristina Morales-Cabeza, Horacio Caligaris, Lei Chen, David González-de-Olano, Óscar González-López, Luis Escribano, Andrés C. García-Montero, María Jara-Acevedo, Alberto Orfao

Blood (2025) 146 (22): 2696–2709.

https://doi.org/10.1182/blood.2025029507

Published: 2025

Includes: Supplemental data

Journal Articles

Proteomic subtypes enrich current acute myeloid leukemia nomenclature and reflect intrinsic pathogenesis alongside aging

Blood (2025) 146 (22): 2681–2695.

https://doi.org/10.1182/blood.2024027692

Published: 2025

Includes: Supplemental data

Journal Articles

Restoring p53 wild-type conformation in TP53 -Y220C–mutant acute myeloid leukemia

Bing Z. Carter, Po Yee Mak, Edward Ayoub, Xiaogang Wu, Baozhen Ke, Yuki Nishida, Andrew Futreal, Lauren B. Ostermann, Andrea D. Bedoy, Steffen Boettcher, Courtney D. DiNardo, Anna Puzio-Kuter, Masha V. Poyurovsky, Arnold Levine, Michael Andreeff

Blood (2025) 146 (21): 2574–2588.

https://doi.org/10.1182/blood.2025028935

Published: 2025

Includes: Supplemental data

Journal Articles

Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemia

Cristiana O’Brien, Nirvana Nursimulu, Anit Tyagi, Rachel Culp-Hill, Andrea Arruda, Tracy Murphy, Mark D. Minden, Andrew Kent, Brett Stevens, Daniel A. Pollyea, Kristin Hope, Sushant Kumar, Julie A. Reisz, Angelo D'Alessandro, Courtney L. Jones

Blood (2025) 146 (21): 2589–2596.

https://doi.org/10.1182/blood.2025029132

Published: 2025

Includes: Supplemental data

Journal Articles

FLAG-IDA plus venetoclax for children, adolescents, and young adults with newly diagnosed AML

Blood (2025) 146 (21): 2608–2611.

https://doi.org/10.1182/blood.2025029391

Published: 2025

Includes: Supplemental data

Journal Articles

NPM1 -mutated acute myeloid leukemia with marked erythroid and megakaryocytic differentiation

Xenia Parisi, Sanam Loghavi

Blood (2025) 146 (21): 2612.

https://doi.org/10.1182/blood.2025030468

Published: 2025

Journal Articles

Glutaredoxin 2 is essential for AML survival through mitochondrial permeability transition pore regulation

Blood blood.2025028933.

https://doi.org/10.1182/blood.2025028933

Published: 2025

Includes: Supplemental data

Journal Articles

HiJAKing the hematopoietic system: a low-frequency JAK2V617F clone drives myeloproliferative neoplasm pathology

Dennis M. Bonal, Alissa Oakes, Anna Chorzalska, Makayla Pardo, Max Petersen, Michael Y. Clarke, Seo-Ho Lee, Adam J. Olszewski, Diana O. Treaba, John L. Reagan, Mark Dooner, John Morgan, Paul Bertone, Ting C. Zhao, Wentian Yang, Corey E. Ventetuolo, Gabriela S. Hobbs, Joslyn Mills, Patrycja M. Dubielecka

Blood (2025) 146 (20): 2428–2442.

https://doi.org/10.1182/blood.2024027125

Published: 2025

Includes: Supplemental data

Journal Articles

Disrupting tRNA modifications to target mitochondrial vulnerabilities in drug-resistant leukemia cells

Blood (2025) 146 (20): 2443–2456.

https://doi.org/10.1182/blood.2024027822

Published: 2025

Includes: Supplemental data

Journal Articles

Utility of Peripheral Blood Testing for Detection and Surveillance of Clonal Hematopoiesis in Predisposed Individuals (CH-IPI)

Blood blood.2024028042.

https://doi.org/10.1182/blood.2024028042

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

The role of CD38 in monocytes during fibrotic progression of myeloproliferative neoplasms

The glycosaminoglycan oncofetal chondroitin sulfate represents a novel target for antibody drug-conjugate therapy for AML

Pharmacological Inhibition of miR-126 Enhances Venetoclax Activity in Acute Myeloid Leukemia

2025 Update on MRD in Acute Myeloid Leukemia: A Consensus Document from the ELN-DAVID MRD Working Party

Microenvironmental cell interactions are essential for sustaining functionality of myelofibrosis malignant stem cells

CUX1 restrains latent hematopoietic stem cell plasticity by suppressing stem cell–intrinsic inflammatory pathways

Fusion gene depletion eliminates stemness and induces bidirectional differentiation of acute myeloid leukemia

Azacitidine to treat measurable residual disease in patients with MDS/AML: final long-term results of the RELAZA2 trial

Impact of ASXL1 at diagnosis in patients with CML receiving frontline potent TKIs: high risk of kinase domain mutations

How I Treat Advanced Phases of CML

Improved diagnostic screening and classification of clonal mast cell diseases by ultrasensitive KIT p.D816V detection

Proteomic subtypes enrich current acute myeloid leukemia nomenclature and reflect intrinsic pathogenesis alongside aging

Restoring p53 wild-type conformation in TP53 -Y220C–mutant acute myeloid leukemia

Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemia

FLAG-IDA plus venetoclax for children, adolescents, and young adults with newly diagnosed AML

NPM1 -mutated acute myeloid leukemia with marked erythroid and megakaryocytic differentiation

Glutaredoxin 2 is essential for AML survival through mitochondrial permeability transition pore regulation

HiJAKing the hematopoietic system: a low-frequency JAK2V617F clone drives myeloproliferative neoplasm pathology

Disrupting tRNA modifications to target mitochondrial vulnerabilities in drug-resistant leukemia cells

Utility of Peripheral Blood Testing for Detection and Surveillance of Clonal Hematopoiesis in Predisposed Individuals (CH-IPI)

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only